Financhill
Sell
20

NXRT Quote, Financials, Valuation and Earnings

Last price:
$37.80
Seasonality move :
10.28%
Day range:
$37.54 - $38.18
52-week range:
$30.02 - $48.37
Dividend yield:
5.14%
P/E ratio:
23.10x
P/S ratio:
3.80x
P/B ratio:
2.35x
Volume:
566.2K
Avg. volume:
153.8K
1-year change:
20.36%
Market cap:
$963.6M
Revenue:
$259.7M
EPS (TTM):
-$0.01

Earnings Data

Next earnings date for NXRT
Apr 30
2025
Most recent earnings per share
-$1.06
Missed by $0.80
(Feb 25/2025)
Consensus Estimate
-$0.26
(Feb 25/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NXRT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/30/2025 Q1 $63.3M -- -- -$0.29 --
02/25/2025 Q4 $64.1M $63.8M -$1.06 -$0.26 -$0.80
10/29/2024 Q3 $64.1M $64.1M -$0.35 -$0.27 -$0.08
07/30/2024 Q2 $64.6M $64.2M $0.40 -$0.26 $0.66
04/30/2024 Q1 $66.8M $67.6M $1.00 $0.29 $0.71
02/20/2024 Q4 $68.2M $68.9M $0.70 -- --
10/31/2023 Q3 -- -- $1.28 -- --
07/25/2023 Q2 -- -- -$0.15 -- --
04/25/2023 Q1 -- -- -$0.15 -$0.16 $0.01
02/21/2023 Q4 -- -- $0.15 $1.82 -$1.67
10/25/2022 Q3 -- -- -$0.02 $2.18 -$2.20
07/26/2022 Q2 -- -- -$0.30 $2.14 -$2.44
04/26/2022 Q1 -- -- -$0.18 -$0.19 $0.01
02/15/2022 Q4 -- -- $1.51 -$0.23 $1.74
11/02/2021 Q3 -- -- -$0.21 $0.37 -$0.58
07/27/2021 Q2 -- -- -$0.14 -$0.25 $0.11
04/27/2021 Q1 -- -- -$0.27 -$0.26 -$0.01
02/16/2021 Q4 -- -- -$0.17 -$0.20 $0.03
10/27/2020 Q3 -- -- $1.19 -$0.23 $1.42
08/04/2020 Q2 -- -- -$0.38 -$0.42 $0.04
05/07/2020 Q1 -- -- $1.08 $0.31 $0.77
02/18/2020 Q4 -- -- -$0.61 -$0.19 -$0.42
10/29/2019 Q3 -- -- $4.84 -- --
07/30/2019 Q2 -- -- -$0.08 -$0.19 $0.11
04/30/2019 Q1 -- -- -$0.19 -$0.20 $0.01
02/19/2019 Q4 -- -- -$0.21 -$0.06 -$0.15
10/30/2018 Q3 -- -- -$0.11 $0.27 -$0.38
07/31/2018 Q2 -- -- -$0.07 $0.10 -$0.17
05/01/2018 Q1 -- -- $0.50 $0.47 $0.03
02/13/2018 Q4 -- -- -$0.21 -$0.12 -$0.09
10/31/2017 Q3 -- -- $2.56 $1.31 $1.25
08/01/2017 Q2 -- -- $0.57 -$0.12 $0.69
05/02/2017 Q1 -- -- -$0.17 $0.03 -$0.20
03/14/2017 Q4 -- -- $0.39 $0.36 $0.03
11/10/2016 Q3 -- -- $0.32 $0.33 -$0.01
08/09/2016 Q2 -- -- $0.34 $0.26 $0.08
05/10/2016 Q1 -- -- $0.41 $0.37 $0.04
03/08/2016 Q4 -- -- -- $0.33 --
11/10/2015 Q3 -- -- $0.37 -- --
08/11/2015 Q2 -- -- $0.34 -- --

NexPoint Residential Trust Earnings Questions

  • How Much did NexPoint Residential Trust Generate in Revenue Last Quarter?

    NexPoint Residential Trust reported $63.8M worth of top line sales in its most recent quarter.

  • Did NexPoint Residential Trust Beat Earnings Last Quarter?

    NexPoint Residential Trust announced earnings per share of -$1.06 which represents a miss of analyst forecast a -$0.26 per share.

  • Is NexPoint Residential Trust Profitable?

    NexPoint Residential Trust reported $36.9M that represents $1.41 per share over the last quarter.

  • What is the Analyst Consensus for NexPoint Residential Trust EPS Next Year?

    NexPoint Residential Trust's earnings are forecast to decrease from $0.04 per share to -$1.21 per share next year representing a decrease of -47.34%.

  • When is NexPoint Residential Trust's Earnings Date?

    NexPoint Residential Trust's next earnings date is April 30, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock